Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10O7 |
Molecular Weight | 302.2357 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C3=CC(O)=C(O)C=C3
InChI
InChIKey=REFJWTPEDVJJIY-UHFFFAOYSA-N
InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H
Molecular Formula | C15H10O7 |
Molecular Weight | 302.2357 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:51:05 UTC 2023
by
admin
on
Sat Dec 16 04:51:05 UTC 2023
|
Record UNII |
9IKM0I5T1E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
664018
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
||
|
DSLD |
1099 (Number of products:1551)
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
||
|
LIVERTOX |
NBK556474
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3514
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
DTXSID4021218
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
D011794
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
100000079143
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
m9420
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB15072MIG
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
341
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
9219
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
204-187-1
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
5280343
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
9IKM0I5T1E
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
C792
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
QUERCETIN
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
9IKM0I5T1E
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
1592409
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
16243
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
117-39-5
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
57655
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
9060
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
3529
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
C401828
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
DB04216
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY | |||
|
57694
Created by
admin on Sat Dec 16 04:51:07 UTC 2023 , Edited by admin on Sat Dec 16 04:51:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
In vitro hydroxyl radical scavenging assay(Hydroxy Radical) IC50 expressed as ug/mL = 0.31 +/- 0.02.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
|
||
|
TRANSPORTER -> INHIBITOR |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
The compound was screened for it's antioxidant capacity in the DPPH assay, and displayed a high antioxidant activity, with an IC50 value of 39.7 uM.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ORAC value expressed as umol TE/g for this compound was 12,300 +/- 1070.
ORAC is a chemical antioxidant assay that is based on the inhibition of the peroxyl-radical induced oxidation initiated by thermal decomposition of AAPH. CAP-e value expressed as GAE/g was 5510 +/- 443.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
To overcome these limitations, QC12, a water-soluble glycine carbamate prodrug of quercetin, was synthesized and evaluated in a clinical study to investigate its pharmacokinetics following oral administrations to cancer patients.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
USP
|
||
|
PARENT -> IMPURITY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |